Outcomes of Endovascular Repair of Aortic Aneurysms with the GORE® Thoracic Branch Endoprosthesis for Left Subclavian Artery Preservation.
AuthorDake, Michael D
Brinkman, William T
Han, Sukgu M
Matsumura, Jon S
Sweet, Matthew P
Patel, Himanshu J
Taylor, Bradley S
Oderich, Gustavo S
JournalJournal of Vascular Surgery
MetadataShow full item record
AbstractObjective or background: Thoracic endovascular aortic repair has emerged as the dominant paradigm for treatment of patients with descending thoracic aortic aneurysms. For aneurysms involving the aortic arch in the region of the left subclavian artery (LSA), branch vessel preservation to maintain blood flow to the LSA is recommended. Branched aortic endografts are an alternative to surgical revascularization of the LSA. Methods: Across 34 investigative sites, 84 patients with Zone 2 aneurysm were enrolled in a nonrandomized, prospective study of a single branched aortic endograft. The thoracic branch endoprosthesis device allows for graft placement proximal to the LSA and incorporates a single side branch for left subclavian perfusion. Results: Over half of the patients were male (63%). Their average age was 70 (±11) years. The aneurysm morphology was fusiform in 43 and saccular in 41 patients. The mean aneurysm diameter at screening was 56.2 mm. The mean follow up was 30 months (range 2.6 to 50.7 months). Reported here are the patient outcomes at 1 and 12 months. Pre-defined technical success with implantation of the device in landing Zone 2 was achieved in 92% (n=77) of patients. There were no cases of aortic rupture, lesion-related mortality, or new onset renal failure. There was no peri-operative (30-day) mortality. A single case each of permanent paraplegia and paraparesis occurred. Three patients experienced a procedure-related stroke. Through 12 months, four patients died; none of the deaths were adjudicated as related to the device or procedure. One aortic reintervention was required. A single case of aortic enlargement (core laboratory) was reported at 6 months. Type 1 (n=3) and III (n=5) endoleaks occurred in 9.8% of patients of which one (Type III) required reintervention. Conclusions: Results from this device study in patients with Zone 2 aneurysm demonstrate that early safety and efficacy outcomes are maintained up to 12 months after the endovascular procedure with low mortality and reintervention rates and an acceptable frequency of procedural complications, including neurologic complications.
Rights/TermsCopyright © 2022. Published by Elsevier Inc.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19279
- Evaluation of the Gore TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysms.
- Authors: Dake MD, Fischbein MP, Bavaria JE, Desai ND, Oderich G, Singh MJ, Fillinger M, Suckow BD, Matsumura JS, Patel HJ
- Issue date: 2021 Nov
- Midterm Outcomes of Endovascular Repair of Aortic Arch Aneurysms with the Gore Thoracic Branch Endoprosthesis.
- Authors: Liang NL, Dake MD, Fischbein MP, Bavaria JE, Desai ND, Oderich GS, Singh MJ, Fillinger M, Suckow BD, Matsumura JS, Patel HJ, Makaroun MS
- Issue date: 2022 Dec
- Periscope endograft technique to revascularize the left subclavian artery during thoracic endovascular aortic repair.
- Authors: Lachat M, Mayer D, Pfammatter T, Criado FJ, Rancic Z, Larzon T, Veith FJ, Pecoraro F
- Issue date: 2013 Dec
- In situ laser fenestration during emergent thoracic endovascular aortic repair is an effective method for left subclavian artery revascularization.
- Authors: Redlinger RE Jr, Ahanchi SS, Panneton JM
- Issue date: 2013 Nov
- Branched Endovascular Therapy of the Distal Aortic Arch: Preliminary Results of the Feasibility Multicenter Trial of the Gore Thoracic Branch Endoprosthesis.
- Authors: Patel HJ, Dake MD, Bavaria JE, Singh MJ, Filinger M, Fischbein MP, Williams DM, Matsumura JS, Oderich G
- Issue date: 2016 Oct